RPLA Research Award
Forecasted
The RPLA Research Award from the American Society for Reproductive Medicine funds innovative research on the causes, mechanisms, diagnosis, and management of recurrent pregnancy loss.
Funder: American Society for Reproductive Medicine
Due Dates (Anticipated): April 2027 (Full application deadline, projected)
Funding Amounts: Up to $40,000 total for a two-year project period; no indirect costs or investigator salary allowed.
Summary: Supports innovative research into the causes, diagnosis, management, or pathogenesis of recurrent pregnancy loss.
Key Information: Application must be submitted as one PDF to research@asrm.org; fellows/postdocs may apply with restrictions.
Description
This award, offered in partnership by the Recurrent Pregnancy Loss Association (RPLA) and the American Society for Reproductive Medicine (ASRM), supports innovative research projects that advance understanding of recurrent pregnancy loss. Eligible projects may address physiological, psychological, biochemical, pharmacological, genetic, environmental, or pathological aspects of recurrent pregnancy loss, including causes, diagnosis, management, or pathogenesis. The program aims to foster impactful research that can improve reproductive health outcomes and further both organizations’ missions.
